Evidence map›Paper›PMID 40493142›Full record

ArticleAIDS and behavior2025

Patterns in Mental Health Symptoms, Substance Use, and Viral Suppression in People with HIV: A Clustering Analysis.

Y Joseph Hwang, Catherine R Lesko, Jarratt D Pytell, Oluwaseun Falade-Nwulia, Joyce L Jones, Jeanne C Keruly, LaQuita N Snow, Richard D Moore, Anthony T Fojo

Abstract read
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Y Joseph HwangDepartment of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street 2-300, Baltimore, MD, 21287, USA. yhwang19@jhmi.edu.ORCID http://orcid.org/0000-0002-0034-2292
Catherine R LeskoDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Jarratt D PytellDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Oluwaseun Falade-NwuliaDepartment of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street 2-300, Baltimore, MD, 21287, USA.
Joyce L JonesDepartment of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street 2-300, Baltimore, MD, 21287, USA.
Jeanne C KerulyDepartment of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street 2-300, Baltimore, MD, 21287, USA.
LaQuita N SnowDepartment of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street 2-300, Baltimore, MD, 21287, USA.
Richard D MooreDepartment of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street 2-300, Baltimore, MD, 21287, USA.
Anthony T FojoDepartment of Medicine, Johns Hopkins University School of Medicine, 2024 E. Monument Street 2-300, Baltimore, MD, 21287, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
Ending the HIV Epidemic in Rural America (EHE-RA): Local Interventions, Co-Epidemics, and Social DeterminantsR01MD018539 · NIMHD · JOHNS HOPKINS UNIVERSITY · PI Anthony Todd Fojo · 2022 to 2026
$4.0M
Ending the HIV Epidemic: Peer-supported collaborative care for mental health and substance use disorder care integration into HIV care settingsR01DA052297 · NIDA · JOHNS HOPKINS UNIVERSITY · PI FALADE-NWULIA, OLUWASEUN · 2020 to 2024
$3.5M
Optimizing outcomes at the intersection of HIV and mental health: Prediction, precision medicine, and population healthK08MH118094 · NIMH · JOHNS HOPKINS UNIVERSITY · PI FOJO, ANTHONY TODD · 2018 to 2022
$953k
Unhealthy alcohol use, other drug use, and mental health disorders: comorbidity burden in people with HIV, gaps in treatment, and impact on the HIV care continuumK01AA028193 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI LESKO, CATHERINE · 2019 to 2023
$900k
Patient Reported Outcome Measures to Individualize Treatment And Improve ReteNtion (ReTAIN) program in primary care-based OUD treatmentK23DA060358 · NIDA · UNIVERSITY OF COLORADO DENVER · PI Jarratt Pytell · 2024 to 2026
$570k
Division of Intramural Research, National Institute of Allergy and Infectious Diseases P30AI094189Intramural Research Program, National Institute on Drug Abuse K23DA060358Intramural Research Program, National Institute on Drug Abuse R01DA052297Intramural Research Program, National Institute on Drug Abuse U01DA036935NIAAA NIH HHS K01 AA028193NIAAA NIH HHS K01AA028193NIAID NIH HHS P30 AI094189NIDA NIH HHS K23 DA060358NIDA NIH HHS R01 DA052297NIDA NIH HHS U01 DA036935NIMHD NIH HHS R01 MD018539NIMHD NIH HHS R01MD018539NIMH NIH HHS K08 MH118094NIMH NIH HHS K08MH118094
6 · The paper itself

Abstract

Mental health conditions and substance use are prevalent among people with HIV (PWH), are correlated with one another, and associate with viral non-suppression independently; their joint association with viral non-suppression may be under-studied because of data sparsity. We conducted a machine learning-based clustering analysis to characterize groups of patient-reported mental health symptoms and substance use based on their relationship with HIV viral suppression. Participants in the Johns Hopkins HIV Clinical Cohort reported symptoms of depression, anxiety, and post-traumatic stress, and recent use of alcohol, cocaine, amphetamine, non-prescribed opioids, and cannabis (2013-2023). We fit a random forest model with the viral suppression status as the outcome against self-reported items as predictors and used a forest-derived similarity measure to group participants into three clusters. The cluster with the lowest viral suppression rate (74.5%) had the highest depression symptom score (median score 4, interquartile interval [IQI] 1-8) and anxiety symptom score (median score 2, IQI 0-7) along with the greatest prevalence of recent cocaine (99.9%) and opioid (28.0%) use. The cluster with the highest HIV viral suppression rate (81.1%) had the lowest depression symptom score (median 1, IQI 0-4) and anxiety symptom score (median 0, IQI 0-2) and lowest proportion of recent cocaine (0%) and opioid (2.5%) use. Clinically meaningful groups of PWH with heterogenous mental health and substance use characteristics were formed using a machine learning-based clustering approach. PWH with mental health symptoms and substance use represent an important subpopulation for interventions to improve antiretroviral treatment outcomes.

Indexed as

HIV InfectionsMental DisordersMental HealthSubstance-Related DisordersAdultAnxietyCluster AnalysisDepressionFemaleHumansMachine LearningMaleMiddle AgedPrevalenceViral LoadHIVMental healthPatient-reported outcomeSubstanceViral suppression

Identifiers

PMID40493142
PMCPMC12596101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.